CompletedNCT02704273
A Clinical Assessment Study in X-Linked Myotubular Myopathy (XLMTM) Subjects
Studying X-linked centronuclear myopathy
Last synced from ClinicalTrials.gov
ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing dataKey facts
- Sponsor
- Astellas Gene Therapies
- Principal Investigator
- Salvador Rico, MD, PhDAudentes Therapeutics
- Enrollment
- 34 enrolled
- Eligibility
- 3 years · MALE
- Timeline
- 2016 – 2019
Study locations (8)
- UCLA, Los Angeles, California, United States
- University of Florida, Gainesville, Florida, United States
- Ann & Robert H. Lurie Children's Hospital of Chicago, Chicago, Illinois, United States
- National Institute of Neurological Disorders and Stroke/NIH Porter, Bethesda, Maryland, United States
- Hospital for Sick Children, Toronto, Ontario, Canada
- Hopital Armand Trousseau, Paris, France
- Ludwig-Maximilians Universität München, Munich, Germany
- Great Ormond Street Hospital, London, United Kingdom
Primary source
Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.
Open NCT02704273 on ClinicalTrials.govOther trials for X-linked centronuclear myopathy
Additional recruiting or active studies for the same condition.
- RECRUITINGPHASE1, PHASE2NCT07052929Study of ASP2957 in Male Participants With X-linked Myotubular Myopathy Who Need VentilatorsAstellas Gene Therapies
- RECRUITINGNCT06581146A Study to Check Liver Health in Boys With XLMTM, a Serious Genetic Muscle ConditionAstellas Gene Therapies
- ACTIVE NOT RECRUITINGPHASE2, PHASE3NCT03199469A Study of AT132 in Young Children With X-Linked Myotubular Myopathy (XLMTM)Astellas Gene Therapies